Representation of Blaine Pharmaceuticals
Representation of Blaine Pharmaceuticals, a privately held Kentucky corporation as corporate counsel.
Representative transactions:
1. Acquisition of Maginex product line from Geist Pharmaceuticals of Indianapolis, Indiana. Participated in and documented acquisition transaction, inclusive of intellectual property encompassing patents, trademarks, inventory and related assets.
2. Acquisition of ReliaDose product line from former owners. Participated in and documented acquisition transaction, inclusive of intellectual property encompassing patents, trademarks, manufacturing relationships and related assets. ReliaDose is a product providing a system for delivery of pediatric medicines to infants, expected to be in widespread retail distribution.
3. Reorganization and recapitalization of Blaine effected to provide investment capital for company expansion and product roll out. Transaction involved complete corporate restructure to accommodate preferential equity investment effected through an exempt private placement transaction.
Representative transactions:
1. Acquisition of Maginex product line from Geist Pharmaceuticals of Indianapolis, Indiana. Participated in and documented acquisition transaction, inclusive of intellectual property encompassing patents, trademarks, inventory and related assets.
2. Acquisition of ReliaDose product line from former owners. Participated in and documented acquisition transaction, inclusive of intellectual property encompassing patents, trademarks, manufacturing relationships and related assets. ReliaDose is a product providing a system for delivery of pediatric medicines to infants, expected to be in widespread retail distribution.
3. Reorganization and recapitalization of Blaine effected to provide investment capital for company expansion and product roll out. Transaction involved complete corporate restructure to accommodate preferential equity investment effected through an exempt private placement transaction.